Inflammatory mass of an intrathecal catheter in patients receiving baclofen as a sole agent: A report of two cases and a review of the identification and treatment of the complication

被引:45
作者
Deer, Timothy R.
Raso, Louis J.
Garten, Tina G.
机构
[1] W Virginia Univ, Ctr Pain Relief, Charleston, WV 25301 USA
[2] W Virginia Univ, Dept Anesthesiol, Charleston, WV 25301 USA
[3] Three Palms Str, Jupiter, FL USA
关键词
granuloma; inflammatory mass; intrathecal; baclofen; spasticity;
D O I
10.1111/j.1526-4637.2006.00150.x
中图分类号
R614 [麻醉学];
学科分类号
100217 [麻醉学];
摘要
Introduction. Intrathecal inflammatory masses or granuloma have been described extensively in the literature in patients receiving chronic spinal infusions for pain. After an extensive literature review, no reported cases of baclofen causing this disorder when administered as a sole agent were identified. Intrathecal baclofen has been used to treat spasticity secondary to stroke, multiple sclerosis, cerebral palsy, spinal cord injury, and other neurological disease. Cases. Two patients who received intrathecal infusions of baclofen to treat spasticity developed catheter failure. Magnetic resonance imaging analysis showed the presence of an inflammatory mass at the tip of each catheter causing the dysfunction. The catheters were removed and replaced by a percutaneous technique. Discussion. Inflammatory mass on an intrathecal catheter can result in a variety of symptoms. These problems range from the patient being asymptomatic to flaccid paraplegia. Animal studies have shown an association with high concentrations of morphine and hydromorphone theorized to be related to a mast cell degranulation response. Presence of this lesion in these two patients should heighten the suspicion for inflammatory mass in any patient treated for spasticity. The diagnosis of intrathecal catheter tip inflammatory mass is made after an initial suspicion of a catheter occlusion or failure. The gold standard of diagnosis is T2-weighted magnetic resonance imaging. A computerized tomography myelogram is acceptable if a magnetic resonance imaging is not feasible. Conclusion. We report two cases of inflammatory mass in patients receiving baclofen as a sole intrathecal agent. The authors would recommend vigilance in any patient receiving intrathecal baclofen. If the suspicion arises of this problem, a magnetic resonance imaging or computerized tomography myelogram should be obtained with a focus on the catheter tip.
引用
收藏
页码:259 / 262
页数:4
相关论文
共 13 条
[1]
Future directions in the management of pain by intraspinal drug delivery [J].
Bennett, G ;
Deer, T ;
Du Pen, S ;
Rauck, R ;
Yaksh, T ;
Hassenbusch, SJ .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 20 (02) :S44-S50
[2]
Inflammatory mass lesions associated with intrathecal drug infusion catheters: Report and observations on 41 patients [J].
Coffey, RJ ;
Burchiel, K .
NEUROSURGERY, 2002, 50 (01) :78-86
[3]
Intrathecal drug delivery for treatment of chronic low back pain: Report from the National Outcomes Registry for Low Back Pain [J].
Deer, T ;
Chapple, I ;
Classen, A ;
Javery, K ;
Stoker, V ;
Tonder, L ;
Burchiel, K .
PAIN MEDICINE, 2004, 5 (01) :6-13
[4]
Deer Timothy R, 2004, Pain Physician, V7, P225
[5]
A prospective study of catheter-related complications of intrathecal drug delivery systems [J].
Follett, KA ;
Naumann, CP .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 19 (03) :209-215
[6]
Management of intrathecal catheter-tip inflammatory masses: A consensus statement [J].
Hassenbusch, S ;
Burchiel, K ;
Coffey, RJ ;
Cousins, MJ ;
Deer, T ;
Hahn, MB ;
Du Pen, S ;
Follett, KA ;
Krames, E ;
Rogers, JN ;
Sagher, O ;
Staats, PS ;
Wallace, M ;
Willis, KD .
PAIN MEDICINE, 2002, 3 (04) :313-323
[7]
Catheter-associated masses in patients receiving intrathecal analgesic therapy [J].
McMillan, MR ;
Doud, T ;
Nugent, W .
ANESTHESIA AND ANALGESIA, 2003, 96 (01) :186-190
[8]
SPINAL-CORD COMPRESSION COMPLICATING SUBARACHNOID INFUSION OF MORPHINE - CASE-REPORT AND LABORATORY EXPERIENCE [J].
NORTH, RB ;
CUTCHIS, PN ;
EPSTEIN, JA ;
LONG, DM .
NEUROSURGERY, 1991, 29 (05) :778-784
[9]
ADMINISTRATION OF INTRASPINAL MORPHINE-SULFATE FOR THE TREATMENT OF INTRACTABLE CANCER PAIN [J].
SHETTER, AG ;
HADLEY, MN ;
WILKINSON, E .
NEUROSURGERY, 1986, 18 (06) :740-747
[10]
Mechanisms of action of intrathecal medications [J].
Simpson, RK .
NEUROSURGERY CLINICS OF NORTH AMERICA, 2003, 14 (03) :353-+